Some corporate executives have seen their wealth soar this year, thanks to stock awards that have gained in value as the stock market rebounded from its plunge at the start of the coronavirus pandemic. And Stéphane Bancel, the chief executive of Moderna, a drug maker developing a coronavirus vaccine, received options in February that have appreciated by nearly $30 million. Not all executives have gains on their 2020 grants, because many companies have struggled in the pandemic. One reason stock awards have appreciated so much is that some of the grants were made when the stock market was close to its lowest point for the year. Of course, many executives are also sitting on gains on stock they got in earlier years.

Source: International New York Times October 09, 2020 10:52 UTC